Legit.Health and LUX MED announce strategic collaboration to bring AI Dermatology to thousands of patients in Poland

BILBAO / WARSAW (December 30, 2025) — Legit.Health, the leading artificial intelligence (AI)-assisted dermatology solution, and LUX MED, part of the Bupa Group, today announce a strategic collaboration that will accelerate the digital transformation of dermatology and enhance care for patients with skin conditions.

LUX MED is part of the Bupa Group, a globally recognised healthcare leader with a worldwide presence and extensive experience in driving innovation and quality of care. Its international reach amplifies the potential impact of this collaboration.

They will incorporate Legit.Health's cutting-edge algorithms, which support the diagnosis and measure the severity of over 323 dermatological conditions using images taken with a mobile phone. This pioneering technology, already in use by hospitals and insurers in several countries, offers accuracy comparable to that of specialist dermatologists and represents a revolutionary step forward in how skin diseases are assessed and monitored.

An Alliance Driving Innovation

Dermatology is an overstretched speciality, characterised by prolonged waiting lists and a growing incidence of chronic skin diseases and skin cancer. Innovation in this field has become critical to ensure faster and more equitable access to healthcare.

The collaboration with LUX MED will enable these capabilities to be implemented in one of Europe's most advanced healthcare ecosystems, opening the door for expansion into new strategic markets.

This agreement represents a milestone in Legit.Health's expansion strategy, as it continues to consolidate its presence in Europe with partnerships that demonstrate its clinical value and capacity for impact. Together with LUX MED, the company will be able to reach more patients and practitioners, taking a decisive step towards its goal of democratising specialist dermatology on an international scale.

Andy Aguilar, CEO and Co-Founder of Legit.Health, highlights: "Technological innovation only makes sense if it improves people's lives. Our commitment is clear: to help the healthcare system, support clinicians, and empower patients. This collaboration with LUX MED will allow us to broaden our impact in Europe and continue moving towards a more accessible, sustainable, and humane model of care."

"We are proud to join forces with a leader like LUX MED to transform the dermatology of the future," she adds.

Empowering Clinical Work

Both organisations share the vision of offering more efficient, precise, and patient-centred care. Integrating Legit.Health into LUX MED will allow clinicians to assess lesions more quickly and consistently, detect warning signs at early stages, and optimise consultation time to focus on what truly matters: the patient.

The explainable AI tools incorporated into the platform also bring transparency to the clinical process, making it easier for professionals to understand which factors influence each prediction and maintain absolute control over their medical judgement.

About Legit.Health

Legit.Health is a medical technology company specialising in AI-powered clinical decision support tools for dermatology. Its CE-marked software helps healthcare professionals improve diagnostic accuracy, standardise severity assessment, and promote better clinical outcomes. With a focus on scientific validation and regulatory compliance, it serves hospitals, clinics, and health systems across Europe. More information: legit.health

About LUX MED

LUX MED Group is a leader in the private health services market in Poland. The company has been providing its comprehensive care services: outpatient, diagnostic, rehabilitation, dental, psychological, hospital and long-term care for 3,000,000 patients. On a daily basis it follows the principles of sustainable development, undertaking numerous initiatives in the areas of social involvement and the environment. LUX MED is the Main Medical Partner of the Polish Olympic Committee and Polish Paralympic Committee. More information: luxmed.pl

Media Contact: Legit.Health Press Office press@legit.health